Comarco (CMRO) 10-Q 16 Jun 15 2016 Q1 Quarterly report Financial data

Document_And_Entity_Informatio

Document And Entity Information	3 Months Ended
	Apr. 30, 2015	Jun. 15, 2015
Entity Registrant Name	Comarco Inc
Entity Central Index Key	22252
Current Fiscal Year End Date	-30
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Entity Common Stock, Shares Outstanding (in shares)		14,644,165
Document Type	10-Q
Document Period End Date	30-Apr-15
Document Fiscal Year Focus	2016
Document Fiscal Period Focus	Q1
Amendment Flag	FALSE

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (Current Period Unaudited) (USD $)	Apr. 30, 2015	Jan. 31, 2015
In Thousands, unless otherwise specified
ASSETS
Cash and cash equivalents	$1,691	$2,140
Accounts receivable due from suppliers	122	122
Other current assets	46	7
Total current assets	1,859	2,269
Property and equipment, net	6	8
Restricted cash	5	5
Total assets	1,870	2,282
LIABILITIES AND STOCKHOLDERS' DEFICIT
Accounts payable	734	737
Accrued liabilities	783	848
Income taxes payable		40
Total current liabilities	1,517	1,625
Total liabilities	1,517	1,625
Commitments and Contingencies
Stockholders' Deficit:
Preferred stock, no par value, 10,000,000 shares authorized; no shares issued or outstanding
Common stock, $0.10 par value, 50,625,000 shares authorized; 14,644,165 and 14,684,165 shares issued and outstanding at April 30, 2015 January 31, 2014, respectively	1,464	1,468
Additional paid-in capital	18,333	18,322
Accumulated deficit	-19,444	-19,133
Total stockholders' deficit	353	657
Total liabilities and stockholders' deficit	$1,870	$2,282

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) (USD $)	Apr. 30, 2015	Jan. 31, 2015
Accounts receivable, reserves	$0	$0
Preferred Stock, Par Value (in dollars per share)	$0	$0
Preferred Stock Shares Authorized (in shares)	10,000,000	10,000,000
Preferred stock, Shares Issued (in shares)	0	0
Preferred Stock, Shares Outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$0.10	$0.10
Common stock, shares authorized (in shares)	50,625,000	50,625,000
Common stock, shares issued (in shares)	14,644,165	14,684,165
Common stock, shares outstanding (in shares)	14,644,165	14,684,165

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended
In Thousands, except Share data, unless otherwise specified	Apr. 30, 2015	Apr. 30, 2014
Selling, general and administrative expenses	$311	$331
Engineering and support expenses		60
	311	391
Operating loss	-311	-391
Interest expense, net		-122
Loss due to change of derivative liabilities		-1,005
Other income, net		200
Loss from operations before income taxes	-311	-1,318
Net loss	($311)	($1,318)
Basic net loss per share (in dollars per share)	($0.02)	($0.09)
Diluted loss per share (in dollars per share)	($0.02)	($0.09)
Weighted-average shares outstanding:
Weighted-average shares outstanding-Basic (in shares)	14,674	14,684
Weighted average shares outstanding - diluted (in shares)	14,674	14,684

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (Unaudited) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Apr. 30, 2015	Apr. 30, 2014
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	($311)	($1,318)
Adjustments to reconcile net loss from continuing operations to net cash used in operating activities:
Depreciation and amortization	2	2
Amortization of loan discount		89
Stock-based compensation expense	7	12
Change in fair value of derivative liabilities		1,005
Changes in operating assets and liabilities
Other assets	-39	-28
Increase (Decrease) in Accounts Payable	-3	-53
Accrued liabilities	-65	-101
Income taxes payable	-40
Net cash used in operating activities	-449	-392
CASH FLOWS FROM FINANCING ACTIVITIES:
Net decrease in cash and cash equivalents	-445	-392
Cash and cash equivalents, beginning of period	2,140	1,096
Cash and cash equivalents, end of period	1,691	704
Supplementary disclosures of cash flow information:
Cash paid for income taxes, net of refunds	$40

Note_1_Organization

Note 1 - Organization	3 Months Ended
	Apr. 30, 2015
Notes to Financial Statements
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	1.            Organization
	Comarco, Inc. was incorporated in California in 1960 and its common stock has been publicly traded since 1971, when it was spun-off from Genge Industries, Inc. Comarco Inc.’s wholly-owned subsidiary, Comarco Wireless Technologies, Inc. (“CWT”), was incorporated in the state of Delaware in September 1993. Comarco and CWT are collectively referred to as “we,” “us,” “our,” “Comarco,” or the “Company”.

Note_2_Current_Developments_Fu

Note 2 - Current Developments, Future Operations, Liquidity and Capital Resources	3 Months Ended
	Apr. 30, 2015
Notes to Financial Statements
Going Concern [Text Block]	2.             Current Developments, Future Operations, Liquidity and Capital Resources
	The condensed financial statements have been prepared assuming that we will continue to operate as a going concern, which contemplates that we will realize returns on our assets and satisfy our liabilities and commitments in the ordinary course of business. Our consolidated financial statements do not reflect any adjustments related to the outcome of this uncertainty. Our future is highly dependent on our ability to successfully resolve our current litigation, capitalize on our portfolio of patents, generate positive cash flows and/or obtain borrowings or raise capital to meet our liquidity needs.
	As previously announced in August 2013, Lenovo Information Products Co., Ltd. (“Lenovo”), our only material customer, notified us of their intention to cease offering our Constellation product, the power adapter we designed and developed for Lenovo, and terminated its relationship with us. We completed shipping product to Lenovo during our third quarter ended November 30, 2013. The loss of Lenovo as a customer eliminated our only source of revenue and has had a material adverse impact on our results of operations.  We have reduced and/or eliminated certain operating expenses to minimize future losses and cash burn and will continue our efforts in this regard.
	Two of our recent litigation matters have concluded. In the Chicony Power Technology, Co. Ltd., (“Chicony”) matter, effective as of May 15, 2014, Chicony entered into a settlement agreement with us that dismissed all claims between the two parties arising from the litigation. Pursuant to the terms of the settlement agreement, Chicony agreed to pay us $7.6 million. Settlement amounts of $4.0 million and $3.6 million were paid on May 16, 2014 and May 30, 2014, respectively. Of the $7.6 million, we retained $6.5 million, after distributing $1.1 million in attorneys’ fees and other costs. In connection with the settlement, certain contract manufacturer costs payable to Chicony totaling $1.1 million were discharged and reflected as a reduction of cost of revenues. In our litigation with ACCO Brands USA LLC and its Computer Products Group division (collectively “Kensington”), on February 4, 2014, we entered into a confidential settlement and licensing agreement with an effective date of February 1, 2014 that establishes a forward royalty program and dismissed all claims between the two parties arising from this matter.
	On March 10, 2014, we filed a lawsuit against Targus Group International, Inc. (“Targus”) for patent infringement, breach of contract, intentional interference with contract, violation of business and professional codes, misrepresentation and fraudulent concealment (the “Federal Action”). Targus sought reexamination of the patents at issue. The Federal Action was voluntarily dismissed without prejudice to re-filing the federal claims.  A state court action for breach of contract, fraudulent concealment, unfair competition and accounting was then filed by us in the Orange County Superior Court on June 5, 2014 (the “State Court Action”).  On December 4, 2014, the Court ordered the State Court Action into arbitration and the arbitration hearing is set for December 2015. We are seeking damages of at least $17 million. Although we intend to vigorously pursue our rights in this case, the outcome of this matter is not determinable as of the date of this report.
	On February 13, 2015, we filed a lawsuit against Best Buy Co., Inc. (“Best Buy”) for patent infringement under the patent laws of the United States. The complaint alleges that certain Best Buy power charging products sold in the United States under the Rocketfish brand infringe the Company’s patented intellectual property. This lawsuit is part of the Company’s ongoing and accelerated efforts to methodically pursue those companies that the Company believes have infringed on the intellectual property estate that the Company has developed over the last 20 years.
	On February 3, 2015, we filed a lawsuit against Apple, Inc. (“Apple”) for patent infringement. The complaint alleges that Apple products sold in the United States utilizing the Apple Lightning® power supply adapter system, including most iPad®, iPhone®, and iPod® products, infringe the Company’s patented intellectual property. This lawsuit represents Comarco’s most significant enforcement effort to date, and demonstrates the Company’s ongoing and accelerated efforts to methodically pursue those companies that the Company believes have infringed on the intellectual property estate that the Company has developed over the last 20 years.
	We believe that our patent portfolio covering key technical aspects of our products could potentially generate a future revenue stream based upon royalties paid to us by others for the use of some or all of our patents in third party products. We continue to explore opportunities to expand, protect, and monetize our patent portfolio, including through the sale or licensing of our patent portfolio. We may or may not resume our traditional activities of producing innovative charging solutions for battery powered devices. There are no assurances that any of these possible opportunities or activities will occur or be successful.
	We had working capital totaling approximately $0.3 million as of April 30, 2015, which includes liabilities of $0.4 million related to the remaining Pillsbury balance and $0.3 million to Zheng Ge for contract manufacturing services. The $0.4 million balance to Pillsbury will be paid, if at all, in the event Comarco obtains any monetary recovery, whether through settlement, judgment or otherwise (Note 6). Regarding the $0.3 million liability to Zheng Ge, it is possible that ultimate resolution may include net settlement, although there is no right of offset currenly (Note 6). We believe that this working capital will allow us to discharge non-contingent and non-disputed liabilities and commitments in the normal course of business over the next twelve months. We are currently generating de minimis revenues and have ceased traditional operations. Our future is highly dependent on our ability to successfully resolve our current litigation, capitalize on our portfolio of patents, generate positive cash flows and obtain borrowings or raise capital to meet our future liquidity needs.
	We have in the past and will in the future analyze alternatives to build and/or preserve value for our stakeholders, including, but not limited to, exploring additional investment and incremental financing from current and/or new investors, the engagement of advisors to assist in exploring strategic options for us as well as identifying potential partnerships for the purpose of monetizing some or all of the our patent portfolio and past, present, and future infringement claims. There can be no assurances that we will be successful in identifying and/or implementing any of these alternatives, or if implemented, that any of these alternatives will successfully preserve or increase shareholder value.

Note_3_Summary_of_Significant_

Note 3 - Summary of Significant Accounting Policies	3 Months Ended
	Apr. 30, 2015
Notes to Financial Statements
Significant Accounting Policies [Text Block]	3.            Summary of Significant Accounting Policies
	The summary of our significant accounting policies presented below is designed to assist the reader in understanding our condensed consolidated financial statements.
	Basis of Presentation
	The accompanying condensed consolidated balance sheet as of January 31, 2015, which has been derived from our audited financial statements, and our unaudited interim condensed consolidated financial statements as of April 30, 2015 included herein have been prepared without audit in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim information and with the instructions for Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by (“GAAP”) for complete financial statements. The Company believes that the disclosures are adequate to make the information presented not misleading when read in conjunction with the audited consolidated financial statements included in the Company’s annual report on Form 10-K for its fiscal year ended January 31, 2015 (the “2015 Form 10-K”), which was filed with the SEC on April 30, 2015. The accounting policies followed by the Company are set forth in Note 2 to the Company’s audited financial statements included in the 2015 Form 10-K. The unaudited interim condensed consolidated financial information presented herein reflects all adjustments, consisting only of normal recurring accruals, which are, in the opinion of management, necessary for a fair presentation of the consolidated results for the interim periods presented. The consolidated results for the three months ended April 30, 2015 are not necessarily indicative of the results to be expected for the fiscal year ending January 31, 2016.
	Principles of Consolidation
	The unaudited interim condensed consolidated financial statements of the Company include the accounts of Comarco, Inc. and CWT, its wholly owned subsidiary. All material intercompany balances, transactions, and profits and losses have been eliminated.
	Cash and Cash Equivalents
	All highly liquid investments with original maturity dates of three months or less when acquired are classified as cash and cash equivalents. The fair value of cash and cash equivalents approximates the amounts shown in the consolidated financial statements. Cash and cash equivalents are generally maintained in uninsured accounts, typically Eurodollar deposits with daily liquidity, which are subject to investment risk including possible loss of
	principal invested.
	Accounts Receivable Due from Suppliers
	Oftentimes we were able to source components locally that we later sold to our contract manufacturers, who built the finished goods, and other suppliers. This was especially the case when new products were initially introduced into production. Sales to our contract manufacturers (or “CMs”) and other suppliers were excluded from revenue and were recorded as a reduction to cost of revenue. As of April 30, 2015, the entire accounts receivable due from suppliers was from Zheng Ge Electrical Co., Ltd. (“Zheng Ge”), a tip supplier for the Bronx product, which was subject to a recall. We ceased paying Zheng Ge during the course of the product recall while we investigated the manufacturing defect which ultimately caused the recall and, likewise, Zheng Ge ceased paying us.
	As of April 30, 2015, we owe Zheng Ge $0.3 million for contract manufacturing services. Although there is no right of offset currenly, it is possible that ultimate resolution may include net settlement. Accordinly, we did not provide an allowance for doubtful accounts against the Zheng Ge receivable.
	Restricted Cash
	Our restricted cash balances are secured by separate bank accounts and represents $5,000 which serves as collateral for credit card chargebacks associated with our internet website.
	Use of Estimates
	The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenue and expenses during the periods reported. Actual results could materially differ from those estimates.
	Certain accounting principles require subjective and complex judgments to be used in the preparation of financial statements. Accordingly, a different financial presentation could result depending on the judgments, estimates, or assumptions that are used. Such estimates and assumptions include, but are not specifically limited to, those required in the assessment of the impairment of long-lived assets, valuation allowances for deferred tax assets, valuation of derivative liabilities and determination of stock-based compensation.
	Fair Value of Financial Instruments
	Our financial instruments include cash and cash equivalents, accounts receivable due from customers and suppliers, accounts payable, accrued liabilities, a short-term loan and derivative liabilities. The carrying amount of cash and cash equivalents, accounts receivable, accounts payable, and accrued liabilities are considered to be representative of their respective fair values because of the short-term nature of those instruments.
	Legal expense classification
	Our legal expenses are classified in either selling, general, and administrative expenses or engineering and support expenses depending on the nature of the legal expense. All legal expenses incurred related to our intellectual property, including associated litigation expense and maintenance of our patent portfolio, are included in engineering and support expenses in our consolidated statement of operations. All other legal expenses, including all other litigation expense and public company legal expense are included in selling, general, and administrative expenses in our consolidated statement of operations.

Note_4_StockBased_Compensation

Note 4 - Stock-Based Compensation	3 Months Ended
	Apr. 30, 2015
Notes to Financial Statements
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	4.           Stock-Based Compensation
	We grant stock awards for a fixed number of shares to employees, consultants, and directors pursuant to the Company’s shareholder-approved equity incentive plans.
	We account for stock-based compensation using the modified prospective method, which requires measurement of compensation cost for all stock awards at fair value on date of grant and recognition of compensation over the service period for awards expected to vest. The fair value of stock options is determined using a Lattice Binomial model for options with performance-based vesting tied to the Company’s stock price and the Black-Scholes valuation model for options with ratable term vesting. Both the Lattice Binomial and Black-Scholes valuation models require the input of subjective assumptions. These assumptions include estimating the length of time optionees will retain their vested stock options before exercising them (the “expected term”), the estimated volatility of our common stock price over the expected term, and the number of awards that will ultimately not complete their vesting requirements (“forfeitures”). Changes in these subjective assumptions can materially affect the estimate of fair value of stock-based compensation and, consequently, the related amount recognized as an expense on the consolidated statements of operations. As required under applicable accounting rules, we review our valuation assumptions at each grant date and, as a result, we are likely to change our valuation assumptions used to value stock-based awards granted in future periods. The values derived from using either the Lattice Binomial or the Black-Scholes model are recognized as an expense over the vesting period, net of estimated forfeitures. The estimation of stock awards that will ultimately vest requires significant judgment. Actual results, and future changes in estimates, may differ from our current estimates.
	The compensation expense recognized is summarized in the table below (in thousands except per share amounts):
			Three Months Ended
			April 30,
			2015				2014
	Stock-based compensation expense		$	7			$	12
	Impact on basic and diluted earnings per share		$	(0.00	)		$	(0.00	)
	The total compensation cost related to nonvested awards not yet recognized is $0.
	During the three months ended April 30, 2015 and 2014, no stock awards were granted.
	Transactions and other information related to stock options granted under these plans for the three months ended April 30, 2015 are summarized below:
			Outstanding Options
							Weighted-Ave.
			Number of				Exercise
			Shares				Price
	Balance, January 31, 2015			600,000			$	0.96
	Options granted			-
	Options canceled or expired			-				-
	Options exercise			-
	Balance, April 30, 2015			600,000			$	0.96
	Stock Options Exercisable at April 30, 2015			560,000			$	0.95
	Transactions and other information related to restricted stock granted under these plans for the three months ended April 30, 2015 are summarized below:
			Outstanding Restricted Stock
							Weighted-Ave.
			Number of				Exercise
			Shares				Price
	Balance, January 31, 2015			390,000			$	0.18
	Restricted stock granted			-				-
	Restricted stock forfeited			(40,000	)			0.18
	Restricted stock vested			(350,000	)			0.18
	Balance, April 30, 2015			-			$	-
	As of April 30, 2015, the stock awards outstanding have an aggregate intrinsic value of $0, based on a closing market price of $0.16 per share on April 30, 2015. The following table summarizes information about the Company’s stock awards outstanding at April 30, 2015:
					Awards Outstanding								Options Exercisable
									Weighted-Ave.
	Range of				Number				Remaining		Weighted-Ave.		Number		Weighted-Ave.
	Exercise/Grant Prices				Outstanding				Contractual Life		Exercise/Grant Price		Exercisable		Exercise Price
	$	0.4				465,000				7.45	$	0.4		465,000	$	0.4
	$	1.09				100,000				3.54		1.09		60,000		1.09
	$	4.53				15,000				2.84		4.53		15,000		4.53
	$	10.43				20,000				1.14		10.43		20,000		10.43
						600,000						0.96		560,000		0.95
	Shares available under the plans for future grants at April 30, 2015 were 229,724 of which 194,500 represent shares that previously were expired, terminated or cancelled and have been added back to the plan and are available for future grants.

Note_5_Net_Loss_Per_Share

Note 5 - Net Loss Per Share	3 Months Ended
	Apr. 30, 2015
Notes to Financial Statements
Earnings Per Share [Text Block]	5.            Net Loss Per Share
	The Company calculates basic loss per share by dividing net loss by the weighted-average number of common shares outstanding during the reporting period. Diluted loss per share reflects the effects of potentially dilutive securities. Since the Company incurred a net loss for the three months ended April 30, 2015, basic and diluted loss per share for this period was the same because the inclusion of dilutive potential common shares related to outstanding stock awards in the calculation would have been antidilutive.
	Potential common shares of 2,950,000 relating to outstanding stock awards to directors and employees have been excluded from diluted weighted average common shares for the three months ended April 30, 2015, as the effect would have been antidilutive.
	Potential common shares of 278,926 relating to outstanding stock awards to directors and employees have been excluded from diluted weighted average common shares for the three months ended April 30, 2014, as the effect would have been antidilutive.
	The following table presents reconciliations of the numerators and denominators of the basic and diluted loss per share computations for net loss. In the tables below, “Net loss” represents the numerator and “Shares” represents the denominator (in thousands, except per share amounts):
		Three Months Ended April 30,
		2015			2014
	Net loss	$	(311	)	$	(1,318	)
	Basic net loss per share:
	Weighted-average shares outstanding-Basic		14,674			14,684
	Basic net loss per share	$	(0.02	)	$	(0.09	)
	Diluted net loss per share:
	Weighted average shares outstanding - basic		14,674			14,684
	Weighted average shares outstanding - diluted		14,674			14,684
	Diluted loss per share	$	(0.02	)	$	(0.09	)

Note_6_Supplier_Concentrations

Note 6 - Supplier Concentrations	3 Months Ended
	Apr. 30, 2015
Notes to Financial Statements
Customer and Supplier Concentrations [Text Block]	6.            Supplier Concentrations
	The suppliers comprising 10 percent or more of the Company’s gross accounts receivable due from suppliers at either April 30, 2015 and January 31, 2015 are listed below (in thousands, except percentages).
		As of April 30,				As of January 31,
		2015				2015
	Total gross accounts receivable due from	$	122	100	%	$	122	100	%
	suppliers
	Supplier concentration:
	Zheng Ge Electrical Co., Ltd.	$	122	100	%	$	122	100	%
		$	122	100	%	$	122	100	%
	Zheng Ge Electrical Co., Ltd. (“Zheng Ge”) was a tip supplier for the Bronx product, which was subject to a recall. We previously sourced some of the component parts that Zheng Ge used in the manufacture of the tips. We ceased paying Zheng Ge during the course of the product recall. Likewise, Zheng Ge ceased paying us.
	The companies comprising 10 percent or more of our gross accounts payable at either April 30, 2015 and January 31, 2015 are listed below (in thousands, except percentages).
		As of April 30,				As of January 31,
		2015				2015
	Total gross accounts payable	$	734	100	%	$	737	100	%
	Supplier concentration:
	Pillsbury Winthrop Shaw Pittman, LLP		432	59	%		432	59	%
		$	432	59	%	$	432	59	%
	Pillsbury Winthrop Shaw Pittman, LLP (“Pillsbury”) was our former legal counsel for the Kensington litigation as well as other patent and intellectual property matters (see Note 13). On May 28, 2014, we entered into an agreement with Pillsbury in which we paid Pillsbury a lump sum of $1.5 million and the remaining balance of $0.4 million (“the Balance”) was modified and is to be paid, if at all, in the event Comarco obtains any monetary recovery, whether through settlement, judgment or otherwise, after May 28, 2014 from or as a result of any of our current or future patent infringement lawsuits. The amount payable shall be equal to the Balance plus 20% per annum, compounded annually from May 28, 2014. In connection with this partial repayment, no gain was recognized.

Note_7_Accrued_Liabilities

Note 7 - Accrued Liabilities	3 Months Ended
	Apr. 30, 2015
Notes to Financial Statements
Accounts Payable and Accrued Liabilities Disclosure [Text Block]	7.            Accrued Liabilities
	Accrued liabilities consist of the following (in thousands):
		April 30,		January 31,
		2015		2015
	Uninvoiced materials and services received	$	331	$	331
	Accrued legal and professional fees		91		138
	Accrued payroll and related expenses		32		38
	Other		329		341
		$	783	$	848
	As of April 30, 2015, approximately $0.3 million or 98 percent of total uninvoiced materials and services of $0.3 million, included in accrued liabilities, were due to Zheng Ge.

Note_8_Commitments_and_Conting

Note 8 - Commitments and Contingencies	3 Months Ended
	Apr. 30, 2015
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	8
	.             Commitments and Contingencies
	Executive Severance Commitments
	We have a severance compensation agreement with our Chief Executive Officer, Thomas Lanni. This agreement requires us to pay Mr. Lanni, in the event of a termination of employment following a change of control of the Company or other circumstances, the amount of his then current annual base salary and the amount of any bonus amount he
	would have achieved for the year in which the termination occurs plus the acceleration of unvested options. We have not recorded any liability in the consolidated financial statements for this agreement.
	Additionally, as a result of the Company’s sale of the 6,250,000 shares of common stock to Elkhorn Partners in 2013, Elkhorn’s beneficial ownership of the Company has increased from approximately 9% to approximately 49% of the Company’s outstanding voting stock, making Elkhorn the Company’s largest shareholder and resulting in a change of control for purposes of the severance compensation agreement. Mr. Lanni has waived his right to receive payments under this agreement as a result of the change in Elkhorn’s beneficial ownership of the Company.
	Executive and Board of Directors Compensation
	On November 2, 2013, the Company approved a deferred compensation plan for its Chief Executive Officer and Board of Directors. As of April 30, 2015, no compensation expense has been accrued under this deferred compensation plan as its goal has not yet been attained.
	Legal Contingencies
	On February 13, 2015, we filed a lawsuit against Best Buy Co., Inc. (“Best Buy”) for patent infringement under the patent laws of the United States. The complaint alleges that certain Best Buy power charging products sold in the United States under the Rocketfish brand infringe the Company’s patented intellectual property. This lawsuit is part of the Company’s ongoing and accelerated efforts to methodically pursue those companies that the Company believes have infringed on the intellectual property estate that the Company has developed over the last 20 years.
	Although we intend to vigorously pursue our rights in this case, the outcome of this matter is not determinable as of the date of this report.
	On February 3, 2015, we filed a lawsuit against Apple, Inc. (“Apple”) for patent infringement. The complaint alleges that Apple products sold in the United States utilizing the Apple Lightning® power supply adapter system, including most iPad®, iPhone®, and iPod® products, infringe the Company’s patented intellectual property. This lawsuit represents Comarco’s most significant enforcement effort to date, and demonstrates the Company’s ongoing and accelerated efforts to methodically pursue those companies that the Company believes have infringed on the intellectual property estate that the Company has developed over the last 20 years. Although we intend to vigorously pursue our rights in this case, the outcome of this matter is not determinable as of the date of this report.
	On March 10, 2014, we filed a lawsuit against Targus Group International, Inc. for patent infringement, breach of contract, intentional interference with contract, violation of business and professional codes, misrepresentation and fraudulent concealment. Targus sought reexamination the patents at issue. The Federal Action was voluntarily dismissed without prejudice to re-filing the federal claims.  A state court action for breach of contract, fraudulent concealment, unfair competition and accounting was then filed in the Orange County Superior Court on June 5, 2014.  On December 4, 2014, the Court ordered the State Court Action into arbitration and the arbitration hearing is set for December 2015. We are seeking damages of at least $17 million. Although we intend to vigorously pursue our rights in this case, the outcome of this matter is not determinable as of the date of this report.
	In addition to the pending matters described above, we are, from time to time, involved in various legal proceedings incidental to the conduct of our business. We are unable to predict the ultimate outcome of these matters.

Note_9_Legal_Settlement

Note 9 - Legal Settlement	3 Months Ended
	Apr. 30, 2015
Notes to Financial Statements
Legal Matters and Contingencies [Text Block]	9
	.
	Legal
	Settlement
	On April 26, 2011, Chicony, the contract manufacturer of the Bronx product that was the subject of a product recall, filed a complaint against us for breach of contract, seeking payment of $1.2 million for the alleged non-payment by us of amounts alleged by Chicony to be due it for products purchased from it by the Company. We denied liability and filed a cross-complaint on May 13, 2011 seeking the recovery of damages of $4.9 million caused by Chicony's failure to adhere to our technical specifications when manufacturing the Bronx product, which we believe resulted in the recall of the product. On April 16, 2013, the court approved our first-amended cross-complaint, which added intentional interference to our complaint and increased the damages we were seeking to at least $15.0 million. On February 4, 2014, a jury returned a verdict in our favor and awarded us damages of approximately $10.8 million, offset by previously accrued liabilities of $1.1 million for a net award of approximately $9.7 million. Effective as of May 15, 2014, Chicony entered into a settlement agreement with us that dismissed all claims between the parties arising from the litigation referenced above. Pursuant to the terms of the settlement agreement, Chicony agreed to pay us $7.6 million in lieu of the jury’s net award of $9.7 million or any other related costs or fees. $4.0 million of the settlement amount was paid to us on May 16, 2014, with the balance of $3.6 million paid to us on May 30, 2014. We recorded a gain of $7.6 million associated with this settlement in the quarter ended July 31, 2014. As a result of the settlement agreement, the $1.1 million payable to Chicony for contract manufacturing costs has been legally dismissed and discharged and recorded as an offset to Cost of Revenues in the quarter ended July 31, 2014.
	Further pursuant to the settlement agreement, each party released the other and its affiliates from any and all claims related to the subject matter of the litigation and we covenanted not to sue Chicony on the next 500,000 power adapters sold by Chicony after May 15, 2014 that we allege infringe on our intellectual property rights. The settlement agreement also contains other representations, warranties and covenants of both parties that are customary for an agreement of this type.
	On September 1, 2011, subsequent to receiving an infringement notification from us, ACCO Brands USA LLC and its Kensington Computer Products Group division (collectively “Kensington”) filed a lawsuit against us alleging that five of our patents relating to power technology are invalid and/or not infringed by products made and/or sold by Kensington. On February 29, 2012, we denied these claims and filed a cross-complaint alleging infringement by Kensington of each of these five patents. On February 4, 2014, Kensington entered into a settlement and licensing agreement with the Company with an effective date of February 1, 2014 that dismissed all claims between the two parties arising from the litigation referenced above.

Significant_Accounting_Policie

Significant Accounting Policies (Policies)	3 Months Ended
	Apr. 30, 2015
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation
	The accompanying condensed consolidated balance sheet as of January 31, 2015, which has been derived from our audited financial statements, and our unaudited interim condensed consolidated financial statements as of April 30, 2015 included herein have been prepared without audit in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim information and with the instructions for Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by (“GAAP”) for complete financial statements. The Company believes that the disclosures are adequate to make the information presented not misleading when read in conjunction with the audited consolidated financial statements included in the Company’s annual report on Form 10-K for its fiscal year ended January 31, 2015 (the “2015 Form 10-K”), which was filed with the SEC on April 30, 2015. The accounting policies followed by the Company are set forth in Note 2 to the Company’s audited financial statements included in the 2015 Form 10-K. The unaudited interim condensed consolidated financial information presented herein reflects all adjustments, consisting only of normal recurring accruals, which are, in the opinion of management, necessary for a fair presentation of the consolidated results for the interim periods presented. The consolidated results for the three months ended April 30, 2015 are not necessarily indicative of the results to be expected for the fiscal year ending January 31, 2016.
Consolidation, Policy [Policy Text Block]	Principles of Consolidation
	The unaudited interim condensed consolidated financial statements of the Company include the accounts of Comarco, Inc. and CWT, its wholly owned subsidiary. All material intercompany balances, transactions, and profits and losses have been eliminated.
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash and Cash Equivalents
	All highly liquid investments with original maturity dates of three months or less when acquired are classified as cash and cash equivalents. The fair value of cash and cash equivalents approximates the amounts shown in the consolidated financial statements. Cash and cash equivalents are generally maintained in uninsured accounts, typically Eurodollar deposits with daily liquidity, which are subject to investment risk including possible loss of
	principal invested.
Accounts Receivable from Suppliers [Policy Text Block]	Accounts Receivable Due from Suppliers
	Oftentimes we were able to source components locally that we later sold to our contract manufacturers, who built the finished goods, and other suppliers. This was especially the case when new products were initially introduced into production. Sales to our contract manufacturers (or “CMs”) and other suppliers were excluded from revenue and were recorded as a reduction to cost of revenue. As of April 30, 2015, the entire accounts receivable due from suppliers was from Zheng Ge Electrical Co., Ltd. (“Zheng Ge”), a tip supplier for the Bronx product, which was subject to a recall. We ceased paying Zheng Ge during the course of the product recall while we investigated the manufacturing defect which ultimately caused the recall and, likewise, Zheng Ge ceased paying us.
	As of April 30, 2015, we owe Zheng Ge $0.3 million for contract manufacturing services. Although there is no right of offset currenly, it is possible that ultimate resolution may include net settlement. Accordinly, we did not provide an allowance for doubtful accounts against the Zheng Ge receivable.
Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]	Restricted Cash
	Our restricted cash balances are secured by separate bank accounts and represents $5,000 which serves as collateral for credit card chargebacks associated with our internet website.
Use of Estimates, Policy [Policy Text Block]	Use of Estimates
	The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenue and expenses during the periods reported. Actual results could materially differ from those estimates.
	Certain accounting principles require subjective and complex judgments to be used in the preparation of financial statements. Accordingly, a different financial presentation could result depending on the judgments, estimates, or assumptions that are used. Such estimates and assumptions include, but are not specifically limited to, those required in the assessment of the impairment of long-lived assets, valuation allowances for deferred tax assets, valuation of derivative liabilities and determination of stock-based compensation.
Fair Value of Financial Instruments, Policy [Policy Text Block]	Fair Value of Financial Instruments
	Our financial instruments include cash and cash equivalents, accounts receivable due from customers and suppliers, accounts payable, accrued liabilities, a short-term loan and derivative liabilities. The carrying amount of cash and cash equivalents, accounts receivable, accounts payable, and accrued liabilities are considered to be representative of their respective fair values because of the short-term nature of those instruments.
Selling, General and Administrative Expenses, Policy [Policy Text Block]	Legal expense classification
	Our legal expenses are classified in either selling, general, and administrative expenses or engineering and support expenses depending on the nature of the legal expense. All legal expenses incurred related to our intellectual property, including associated litigation expense and maintenance of our patent portfolio, are included in engineering and support expenses in our consolidated statement of operations. All other legal expenses, including all other litigation expense and public company legal expense are included in selling, general, and administrative expenses in our consolidated statement of operations.

Note_4_StockBased_Compensation1

Note 4 - Stock-Based Compensation (Tables)	3 Months Ended
	Apr. 30, 2015
Notes Tables
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]			Three Months Ended
			April 30,
			2015				2014
	Stock-based compensation expense		$	7			$	12
	Impact on basic and diluted earnings per share		$	(0.00	)		$	(0.00	)
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]			Outstanding Options
							Weighted-Ave.
			Number of				Exercise
			Shares				Price
	Balance, January 31, 2015			600,000			$	0.96
	Options granted			-
	Options canceled or expired			-				-
	Options exercise			-
	Balance, April 30, 2015			600,000			$	0.96
	Stock Options Exercisable at April 30, 2015			560,000			$	0.95
Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block]			Outstanding Restricted Stock
							Weighted-Ave.
			Number of				Exercise
			Shares				Price
	Balance, January 31, 2015			390,000			$	0.18
	Restricted stock granted			-				-
	Restricted stock forfeited			(40,000	)			0.18
	Restricted stock vested			(350,000	)			0.18
	Balance, April 30, 2015			-			$	-
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block]					Awards Outstanding								Options Exercisable
									Weighted-Ave.
	Range of				Number				Remaining		Weighted-Ave.		Number		Weighted-Ave.
	Exercise/Grant Prices				Outstanding				Contractual Life		Exercise/Grant Price		Exercisable		Exercise Price
	$	0.4				465,000				7.45	$	0.4		465,000	$	0.4
	$	1.09				100,000				3.54		1.09		60,000		1.09
	$	4.53				15,000				2.84		4.53		15,000		4.53
	$	10.43				20,000				1.14		10.43		20,000		10.43
						600,000						0.96		560,000		0.95

Note_5_Net_Loss_Per_Share_Tabl

Note 5 - Net Loss Per Share (Tables)	3 Months Ended
	Apr. 30, 2015
Notes Tables
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]		Three Months Ended April 30,
		2015			2014
	Net loss	$	(311	)	$	(1,318	)
	Basic net loss per share:
	Weighted-average shares outstanding-Basic		14,674			14,684
	Basic net loss per share	$	(0.02	)	$	(0.09	)
	Diluted net loss per share:
	Weighted average shares outstanding - basic		14,674			14,684
	Weighted average shares outstanding - diluted		14,674			14,684
	Diluted loss per share	$	(0.02	)	$	(0.09	)

Note_6_Supplier_Concentrations1

Note 6 - Supplier Concentrations (Tables)	3 Months Ended
	Apr. 30, 2015
Notes Tables
Schedule of Accounts Receivable by Major Suppliers by Reporting Segments [Table Text Block]		As of April 30,				As of January 31,
		2015				2015
	Total gross accounts receivable due from	$	122	100	%	$	122	100	%
	suppliers
	Supplier concentration:
	Zheng Ge Electrical Co., Ltd.	$	122	100	%	$	122	100	%
		$	122	100	%	$	122	100	%
Equity Method Investments [Table Text Block]		As of April 30,				As of January 31,
		2015				2015
	Total gross accounts payable	$	734	100	%	$	737	100	%
	Supplier concentration:
	Pillsbury Winthrop Shaw Pittman, LLP		432	59	%		432	59	%
		$	432	59	%	$	432	59	%

Note_7_Accrued_Liabilities_Tab

Note 7 - Accrued Liabilities (Tables)	3 Months Ended
	Apr. 30, 2015
Notes Tables
Schedule of Accrued Liabilities [Table Text Block]		April 30,		January 31,
		2015		2015
	Uninvoiced materials and services received	$	331	$	331
	Accrued legal and professional fees		91		138
	Accrued payroll and related expenses		32		38
	Other		329		341
		$	783	$	848

Note_2_Current_Developments_Fu1

Note 2 - Current Developments, Future Operations, Liquidity and Capital Resources (Details Textual) (USD $)	0 Months Ended	3 Months Ended		1 Months Ended	0 Months Ended
	Dec. 04, 2014	Apr. 30, 2015	Apr. 30, 2014	30-May-14	30-May-14	15-May-14	16-May-14	Feb. 04, 2014	Jan. 31, 2015
Increase (Decrease) in Accounts Payable		($3,000)	($53,000)
Legal Contingency Damage Seeking Value	17,000,000
Working Capital		300,000
Liabilities, Current		1,517,000							1,625,000
Chicony Power Technology Company Ltd [Member] | Net of Attorneys Fees [Member]
Proceeds from Legal Settlements				6,500,000
Chicony Power Technology Company Ltd [Member] | Cost of Sales [Member]
Increase (Decrease) in Accounts Payable				-1,100,000
Chicony Power Technology Company Ltd [Member]
Litigation Settlement, Amount						7,600,000	7,600,000	9,700,000
Proceeds from Legal Settlements				3,600,000	3,600,000		4,000,000
Professional Fees				1,100,000
Pillsbury Winthrop Shaw Pittman L L P [Member] | Litigation Reserve [Member
Liabilities, Current		400,000
Zheng Ge Electrical Company Ltd [Member] | Litigation Reserve [Member
Liabilities, Current		$300,000

Note_3_Summary_of_Significant_1

Note 3 - Summary of Significant Accounting Policies (Details Textual) (USD $)	Apr. 30, 2015	Jan. 31, 2015
Accounts Payable and Other Accrued Liabilities	$300,000
Collateral for Credit Card [Member]
Restricted Cash and Cash Equivalents		$5,000

Note_4_StockBased_Compensation2

Note 4 - Stock-Based Compensation (Details Textual) (USD $)	3 Months Ended
	Apr. 30, 2015	Apr. 30, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	0	0
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized	$0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value	$0
Share Price	$0.16
Common Stock, Capital Shares Reserved for Future Issuance	229,724
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period	194,500

Note_4_StockBased_Compensation3

Note 4 - Stock-Based Compensation - Share-Based Compensation Expense (Details) (USD $)	3 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Apr. 30, 2015	Apr. 30, 2014
Stock-based compensation expense	$7	$12
Impact on basic and diluted earnings per share (in dollars per share)	$0	$0

Note_4_StockBased_Compensation4

Note 4 - Stock-Based Compensation - Stock Option Activity (Details) (USD $)	3 Months Ended
	Apr. 30, 2015
Balance (in shares)	600,000
Balance weighted average exercise price (in dollars per share)	$0.96
Options granted (in shares)	0
Options granted weighted average exercise price (in dollars per share)	$0
Options canceled or expired (in shares)	0
Options canceled or expired weighted average exercise price (in dollars per share)	$0
Options exercise (in shares)	0
Options exercise weighted average exercise price (in dollars per share)	$0
Balance (in shares)	600,000
Balance weighted average exercise price (in dollars per share)	$0.96
Stock Options Exercisable at April 30, 2015 (in shares)	560,000
Stock Options Exercisable at April 30, 2015 weighted average exercise price (in dollars per share)	$0.95

Note_4_StockBased_Compensation5

Note 4 - Stock-Based Compensation - Restricted Stock Activity (Details) (Restricted Stock [Member], USD $)	3 Months Ended
	Apr. 30, 2015
Restricted Stock [Member]
Balance, January 31, 2015 (in shares)	390,000
Balance, January 31, 2015 (in dollars per share)	$0.18
Restricted stock granted (in shares)	0
Restricted stock granted weighted average exercise price (in dollars per share)	$0
Restricted stock forfeited (in shares)	-40,000
Restricted stock forfeited weighted average exercise price (in dollars per share)	$0.18
Restricted stock vested (in shares)	-350,000
Restricted stock vested weighted average exercise price (in dollars per share)	$0.18
Balance, April 30, 2015 (in shares)	0
Balance, April 30, 2015 (in dollars per share)	$0

Note_4_StockBased_Compensation6

Note 4 - Stock-Based Compensation - Stock Awards Outstanding (Details) (USD $)	3 Months Ended
	Apr. 30, 2015
Range of exercise/grant prices (in dollars per share)	$0.96
Number outstanding (in shares)	600,000
Options exercisable (in shares)	560,000
Options exercisable weighted-ave. exercise price (in dollars per share)	$0.95
Range 1 [Member]
Range of exercise/grant prices (in dollars per share)	$0.40
Number outstanding (in shares)	465,000
Awards outstanding weighted-ave. remaining contractual life	7 years 164 days
Options exercisable (in shares)	465,000
Options exercisable weighted-ave. exercise price (in dollars per share)	$0.40
Range 2 [Member]
Range of exercise/grant prices (in dollars per share)	$1.09
Number outstanding (in shares)	100,000
Awards outstanding weighted-ave. remaining contractual life	3 years 197 days
Options exercisable (in shares)	60,000
Options exercisable weighted-ave. exercise price (in dollars per share)	$1.09
Range 3 [Member]
Range of exercise/grant prices (in dollars per share)	$4.53
Number outstanding (in shares)	15,000
Awards outstanding weighted-ave. remaining contractual life	2 years 306 days
Options exercisable (in shares)	15,000
Options exercisable weighted-ave. exercise price (in dollars per share)	$4.53
Range 4 [Member]
Range of exercise/grant prices (in dollars per share)	$10.43
Number outstanding (in shares)	20,000
Awards outstanding weighted-ave. remaining contractual life	1 year 51 days
Options exercisable (in shares)	20,000
Options exercisable weighted-ave. exercise price (in dollars per share)	$10.43

Note_5_Net_Loss_Per_Share_Deta

Note 5 - Net Loss Per Share (Details Textual) (Stock Compensation Plan [Member])	3 Months Ended
	Apr. 30, 2015	Apr. 30, 2014
Stock Compensation Plan [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	2,950,000	278,926

Note_5_Net_Income_Per_Share_Su

Note 5 - Net Income Per Share - Summary of Basic and Diluted Earnings Per Share (Details) (USD $)	3 Months Ended
In Thousands, except Share data, unless otherwise specified	Apr. 30, 2015	Apr. 30, 2014
Net loss	($311)	($1,318)
Basic net loss per share:
Weighted-average shares outstanding-Basic (in shares)	14,674	14,684
Basic net loss per share (in dollars per share)	($0.02)	($0.09)
Diluted net loss per share:
Weighted-average shares outstanding-Basic (in shares)	14,674	14,684
Weighted average shares outstanding - diluted (in shares)	14,674	14,684
Diluted loss per share (in dollars per share)	($0.02)	($0.09)

Note_6_Supplier_Concentrations2

Note 6 - Supplier Concentrations (Details Textual) (Pillsbury Winthrop Shaw Pittman L L P [Member], USD $)	28-May-14
In Millions, unless otherwise specified
Pillsbury Winthrop Shaw Pittman L L P [Member]
Lump Sum Legal Fee	$1.50
Accrued Professional Fees	$0.40
Interest Rate for Outstanding Legal Fees Payable Solely with Settlement	20.00%

Note_6_Supplier_Concentrations3

Note 6 - Supplier Concentrations - Supplier Concentration Risk Accounts Receivable (Details) (USD $)	3 Months Ended	12 Months Ended
In Thousands, unless otherwise specified	Apr. 30, 2015	Jan. 31, 2015
Accounts receivable due from suppliers	$122	$122
Accounts receivable due from suppliers, percentage	100.00%	100.00%
Supplier concentration:
Accounts receivable due from suppliers	122	122
Accounts receivable due from suppliers, percentage	100.00%	100.00%
Account Receivable from Suppliers [Member] | Zheng Ge Electrical Company Ltd [Member]
Accounts receivable due from suppliers	122	122
Accounts receivable due from suppliers, percentage	100.00%	100.00%
Supplier concentration:
Accounts receivable due from suppliers	122	122
Accounts receivable due from suppliers, percentage	100.00%	100.00%
Account Receivable from Suppliers [Member]
Accounts receivable due from suppliers	122	122
Accounts receivable due from suppliers, percentage	100.00%	100.00%
Supplier concentration:
Accounts receivable due from suppliers	$122	$122
Accounts receivable due from suppliers, percentage	100.00%	100.00%

Note_6_Supplier_Concentrations4

Note 6 - Supplier Concentrations - Supplier Concentration Risk Accounts Payable (Details) (USD $)	3 Months Ended	12 Months Ended
In Thousands, unless otherwise specified	Apr. 30, 2015	Jan. 31, 2015
Accounts payable	$734	$737
Accounts receivable due from suppliers, percentage	100.00%	100.00%
Supplier concentration:
Accounts payable	734	737
Accounts receivable due from suppliers, percentage	100.00%	100.00%
Supplier Concentration Risk [Member] | Accounts Payable [Member] | Pillsbury Winthrop Shaw Pittman L L P [Member]
Accounts payable	432	432
Accounts receivable due from suppliers, percentage	59.00%	59.00%
Supplier concentration:
Accounts payable	432	432
Accounts receivable due from suppliers, percentage	59.00%	59.00%
Supplier Concentration Risk [Member] | Accounts Payable [Member]
Accounts payable	432	432
Accounts receivable due from suppliers, percentage	59.00%	59.00%
Supplier concentration:
Accounts payable	$432	$432
Accounts receivable due from suppliers, percentage	59.00%	59.00%

Note_7_Accrued_Liabilities_Det

Note 7 - Accrued Liabilities (Details Textual) (USD $)	3 Months Ended
	Apr. 30, 2015
Loss Contingencies [Line Items]
Accounts Payable and Other Accrued Liabilities	$300,000
Zheng Ge Electrical Company Ltd [Member] | Uninvoiced Materials and Services [Member]
Loss Contingencies [Line Items]
Accounts Payable and Other Accrued Liabilities	300,000
Percent of Total Uninvoiced Materials and Services	98.00%
Zheng Ge Electrical Company Ltd [Member] | Total Uninvoiced Materials and Services [Member]
Loss Contingencies [Line Items]
Accounts Payable and Other Accrued Liabilities	$300,000

Note_7_Accrued_Liabilities_Acc

Note 7 - Accrued Liabilities - Accrued Liabilities (Details) (USD $)	Apr. 30, 2015	Jan. 31, 2015
In Thousands, unless otherwise specified
Accrued liabilites	$783	$848
Uninvoiced Materials and Services Received [Member]
Accrued liabilites	331	331
Accrued Legal and Professional Fees [Member]
Accrued liabilites	91	138
Accrued Payroll and Related Expenses [Member]
Accrued liabilites	32	38
Accrued Other Liabilities [Member]
Accrued liabilites	$329	$341

Note_8_Commitments_and_Conting1

Note 8 - Commitments and Contingencies (Details Textual) (USD $)	0 Months Ended
In Millions, except Share data, unless otherwise specified	Dec. 04, 2014	Apr. 30, 2015	Jan. 31, 2015	Feb. 11, 2013
Debt Instrument [Line Items]
Common Stock, Shares, Issued		14,644,165	14,684,165	6,250,000
Legal Contingency Damage Seeking Value	$17
Previous Ownership Percentage [Member]
Debt Instrument [Line Items]
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners		9.00%
New Ownership Percentage [Member]
Debt Instrument [Line Items]
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners		49.00%

Note_9_Legal_Settlement_Detail

Note 9 - Legal Settlement (Details Textual) (USD $)	1 Months Ended	0 Months Ended				1 Months Ended	3 Months Ended
In Millions, unless otherwise specified	Apr. 26, 2011	Feb. 04, 2014	30-May-14	15-May-14	16-May-14	30-May-14	Jul. 31, 2014	Feb. 29, 2012	Sep. 02, 2011	13-May-11	Apr. 16, 2013
Loss Contingencies [Line Items]
Loss Contingency, Damages Sought, Value	$1.20
Loss Contingency Amount Claimed for Recovery of Damages										4.9
Number of Patents Relating to Power Technology									5
Number of Comaro Patents								5
Additional Damages Sought [Member]
Loss Contingencies [Line Items]
Gain Contingency, Unrecorded Amount											15
Gross Amount [Member] | Chicony Power Technology Company Ltd [Member]
Loss Contingencies [Line Items]
Litigation Settlement, Amount		10.8
Chicony Power Technology Company Ltd [Member]
Loss Contingencies [Line Items]
Litigation Settlement, Amount		9.7		7.6	7.6
Previously Accrued Seeking Payments		1.1
Proceeds from Legal Settlements			3.6		4	3.6
Gain (Loss) Related to Litigation Settlement							$7.60
Number of Units Under Indemnity Agreement				500,000